Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dynavax Technologies Corp (NASDAQ:DVAX)

4.70
Delayed Data
As of Dec 02
 +0.35 / +8.05%
Today’s Change
3.20
Today|||52-Week Range
29.86
-80.55%
Year-to-Date

Today’s Trading

Previous close4.35
Today’s open4.35
Day’s range4.25 - 4.80
Volume1,483,257
Average volume (3 months)1,879,527
Market cap$167.6M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+5.80%
Earnings growth (this year)+1.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.29%
P/E ratioNM
Price/Sales196.15
Price/Book0.89

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...-0.10-1.09%
AKAOAchaogen Inc-0.26-4.42%
ITEKInotek Pharmaceutica...+0.25+3.88%
EGLTEgalet Corp+0.31+4.48%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$4.1M
Annual profit (last year)-$106.8M
Net profit margin-2,636.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts


Search for Jobs